Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 1-12 of 2,301
Behavioral study icon
RecruitingNCT07111390

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

This study is looking at whether 60Hz Intermittent Light Therapy can help people with Depression, Mdd, or Major Depressive Episode. Participants take part in 60Hz Intermittent Light Therapy and complete follow-up assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 24 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Depression
Behavioral study icon
RecruitingNCT06976697

Home-Based tDCS Treatment Of Major Depressive Disorder

This study is looking at care and outcomes for people with depression. Some participants may receive Sham treatment instead of the study treatment, and direct benefit is not guaranteed.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 22 Years to 70 Years
Countries
United States
Sponsor
Sooma Medical Inc
Condition
Depression
Device study icon
RecruitingNCT07217223

Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

This study is looking at care and outcomes for people with Treatment Resistant Depression or depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 85 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
RecruitingNCT06705478

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

This study is recruiting in the United States, in Botswana, in Brazil, .... It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States, Botswana, Brazil, ...
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Depression
Device study icon
Not Yet RecruitingNCT06470035

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

This study is looking at whether Active VeNS Device can help people with depression \(depression or major depression. Participants take part in Active VeNS Device and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 80 Years
Countries
United States, United Kingdom
Sponsor
Neurovalens Ltd.
Condition
Depression
Drug study icon
RecruitingNCT07139834

Pattern Separation in Major Depressive Disorder

This study is comparing SSRI (escitalopram or sertraline) with placebo for people with depression. Participants receive SSRI (escitalopram or sertraline) or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jeffrey Miller
Condition
Depression
Drug study icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT07226661

Study in Adults With Major Depressive Disorder

This study is recruiting in the United States. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Device study icon
Not Yet RecruitingNCT07528157

Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07503002

Shortened LSD Intervention for Major Depressive Disorder

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 70 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.